1John F C, Bhuvanesh S, Dennis H K. Hemangiopericytoma of head and neck[J]. Laryngoscope, 1999,109(9) : 1409-1411.
2Iwamuro M, Nakamura S, Shiraha H. A case of primary in- tracranial hemangiopericytoma with hepatic metastases: successful treatment with radiofrequency ablation and transcatheter arterial chemoembolization[J]. Clin J Gastroenterol, 2009,2 ( 1 ) : 30-35.
3Ghaffar H, Parwani A, Rosenthal D L. Fine needle aspiration cytology of hepatic metastasis from a meningeal hemangiopericytoma. A case report[J]. Acta Cytol, 2003,47(2):281-286.
8Noriko N, Hiroshi H, Michio K. Recurrent hemangiopericytoma of the liver: Report of a case[J]. Surg Today Jpn J Surg, 1995,25(1):72-75.
9Spatola C, Privitera G. Recurrent intracranial hemangiopericytoma with extraeraniai and unusual multiple metastases: case re port and review of the literature[J]. Tumori, 2004,90 : 265-268.
10Borg M F, Benjamin C S. Hemangiopericytoma of the central nervous system[J]. Australas Radiol,1995,39(1) :36-41.
4:iotta i. A. Tumor invasion and metastases role of the extracel hdar matrix: Rhoads Memorial Award lecture[J]. Cancer Res, 1986, 46(1):1-7.
5Ellenrieder V, Adeler G, Gress T M, et al. Invasion and metastasis in pancreatic cancer[J]. Ann Oncol, 1999. 10(Suppl 1): 46-50.
6Gandolfo G M, Conyi L, Vercillo M, et al. Fibrinolysis components as prognostic markers in breast cancer and colorectal carcinoma[J]. Anticancer Res, 1996, 16(4B): 2155-2161.
7Liu G, Shuman M A, Cohen R L, et al. Co expression ofurokinase, urokinase receptor and Pal-1 is necessary for optimum invasivenessof cultured lung cancer cells[J]. Int J Cancer, 1995. 60(4):501-506.
8Vohn M, Mattem J, Koomagi R. Relationship of urokinase and urokinase receptor in non small cell lung cancer to proliferation, angiogenesis, metastasis and patients survival[J]. Oncol Rep. 1999. 6(3):611-615.
9Stephan B, Florian D, Bjqrn N, et al. A pooled analysis of bone marrow micrometastasis in breast cancer[J]. N Engl J Med, 2005, 353(8): 793-802.
10Gottfried K, Michael U. Astrid P, et al. Association of urokinase type plasminogen activator and its inhibitor with disease progression and prognosis in ovarian cancer[J]. Clinical Cancer Res, 2001, 6(7):1743-1749.
4Al6n JF, Lobato RD, G6mez PA, et al. Intracranialhemangiopericytoma: study of 12 cases [J]. Acta Neurochir(Wien) ,2001,143(6) :575-586.
5Huisman TA, Brandner S, Niggli F, et al. Meningealhemangiopericytoma in childhood [ J]. Eur Radiol,2000,10 (7):1073-1075.
6Hattingen E,Pilatus U,Good C,et al. An unusual intraventricularhaemangiopericytoma: MRI and spectroscopy [J]. Neuroradiology,2003,45(6) :386-389.
7Soyuer S, Chang EL, Selek U,et aL Intracranial meningealhemangiopericytoma: the role of radiotherapy: report of 29 casesand review of the literature [ J]. Cancer, 2004, 100 (7) : 1491-1497.
8Ecker RD,Marsh WR, Pollock BE, et al. Hemangiopericytoma inthe central nervous system : treatment, pathological features, andlong-term follow up in 38 patients [ J]. J Neurosurg,2003,98(6):1182-1187.
9Mena H,Ribas JL,Pezeshkpour GH,et al. Hemangiopericytoma ofthe central nervous system: a review of 94 cases [ J]. Hum Pathol,1991,22(1) :84-91.
